Skip to main content
. 2018 Sep 24;9(10):988. doi: 10.1038/s41419-018-1015-x

Fig. 4. Overexpressing VDAC2 impairs the stem-associated properties of GSCs.

Fig. 4

a Western blot analyses of the GSC markers (CD133, SOX2, and OLIG2) and VDAC2 in GSCs expressing VDAC2 or control vector. b In vitro limiting dilution assay of the self-renewal capacity of GSCs expressing VDAC2 or control vector. Ectopic expression of VDAC2 decreases GSC self-renewal capacity (***p < 0.001). c, d Representative bioluminescent images (c) and the quantification (d) of xenografts derived from GSCs expressing VDAC2 or control vector at day 10 and day 20 after tumor cell implantation. VDAC2 overexpression markedly suppresses GSC-driven tumor formation. p photons, sr steradian (***p < 0.001). e Kaplan–Meier survival analysis of mice bearing xenografts derived from GSCs expressing VDAC2 or control vector. n = 5/group. f, g Quantification of the level of VDAC2 (f) or GSC marker SOX2 (g) in GBM xenografts derived from GSCs expressing VDAC2 or control vector through IHC staining (***p < 0.001)